Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. (Q50183859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

23 December 2019

main subject

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

2

Mark A Pallansch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

Radboud J Duintjer Tebbens

23 December 2019

1

object named as

Radboud J Duintjer Tebbens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

7

Roland W Sutter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

6

Stephen L Cochi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

3

Olen M Kew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Victor M Cáceres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Hamid Jafari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

R Bruce Aylward

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

1471-1505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184393%20AND%20SRC:MED&resulttype=core&format=json

"Endgame" Issues for the Global Polio Eradication Initiative

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Costs and benefits of polio eradication: a long-run global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Forty years and four surveys: how does our measuring measure up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Recombinant vaccine-derived poliovirus in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Long-term excretion of vaccine-derived poliovirus by a healthy child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Search for poliovirus long-term excretors among patients affected by agammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Isolation of vaccine-derived polioviruses in the Slovak Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Vaccine-derived poliovirus, Thailand, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Paralytic poliomyelitis in a child with agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Polio eradication: the OPV paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X

Outbreaks of paralytic poliomyelitis, 1976-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00827.X